Clinical Trial Update: Treatment of Psychotic Major Depression With Mifepristone [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating mifepristone for psychotic major depression was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorders
• Major Depressive Disorder with Psychotic Features

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Stanford University | Conditions: Affective Disorders, Psychotic, Depressive Disorder | Phase 3 | Status: TERMINATED | Results posted: 2017-04-04